Evidence map›Paper›PMID 37630266›Full record

ArticleMolecules (Basel, Switzerland)2023

Ferulic Acid Induces Autophagy and Apoptosis in Colon Cancer CT26 Cells via the MAPK Pathway.

Shanbin Chen, Dong Zhao, Chunguang Luan, Jia Zheng, Wei Liu, Zheng Feng, Ruiqi Luo, Xinglin Han, Deliang Wang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Pharmaceuticals (Basel, Switzerland) · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. World journal of experimental medicine · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Shanbin ChenChina National Research Institute of Food and Fermentation Industries, Beijing 100015, China.
Dong ZhaoYibin Wuliangye Co., Ltd., Yibin 644000, China.
Chunguang LuanChina National Research Institute of Food and Fermentation Industries, Beijing 100015, China.ORCID 0000-0002-3132-6703
Jia ZhengYibin Wuliangye Co., Ltd., Yibin 644000, China.
Wei LiuChina National Research Institute of Food and Fermentation Industries, Beijing 100015, China.
Zheng FengYibin Wuliangye Co., Ltd., Yibin 644000, China.
Ruiqi LuoChina National Research Institute of Food and Fermentation Industries, Beijing 100015, China.
Xinglin HanChina National Research Institute of Food and Fermentation Industries, Beijing 100015, China.
Deliang WangChina National Research Institute of Food and Fermentation Industries, Beijing 100015, China.
China National Research Institute of Food and Fermentation · CNYibin University · CN

Funding

the Key R&D projects in Xinjiang Uygur Autonomous Region Grant No. 2022A02002-2
6 · The paper itself

Abstract

Ferulic acid (FA) is a bioactive compound found in traditional Chinese herbal medicine; for example, it is present in Xinjiang Ferula, but also in strong-flavor Chinese baijiu. FA has been shown to play a crucial role in treating oxidative stress, skin whitening, and eye diseases. In this study, the potential role of FA as a means of inducing apoptosis and inhibiting colon cancer induced by the transplantation of CT26 cells was investigated. The results show that FA adjuvant treatment caused an upregulation in the expression of genes related to autophagy while simultaneously suppressing the expression of inflammatory response elements and improving the bodyweight, glutamic pyruvic transaminase (ALT), and glutamic oxaloacetic transaminase (AST) in vivo. Furthermore, FA inhibited the proliferation of CT26 cells and induced apoptosis, specifically by activating the phosphorylation of ERK and JNK to enhance the essential proteins BCL-2 and BAX in the apoptosis pathway. These results suggest that FA could be a promising auxiliary therapeutic agent for the treatment of colon cancer. Further research is needed to better understand the mechanisms underlying the beneficial effects of FA and its synergistic effects with other compounds.

Indexed as

Colonic NeoplasmsApoptosisAutophagyCoumaric AcidsHumansCoumaric Acidsferulic acidapoptosisautophagyferulic acidMAPK pathway

Identifiers

PMID37630266
PMCPMC10458248
OpenAlexW4385759114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.